Victoza Sales Data
| Rank 60 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: May 2013 (updated quarterly).
The following data shows Victoza U.S. retail sales in Q1 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q1 2013 | 60 ( 8) |
$242,143 | 6.43% | 607 | 9.76% |
| Q4 2012 | 68 (6) |
$227,520 | 8.78% | 553 | 7.17% |
| Q3 2012 | 74 (24) |
$209,163 | 27.22% | 516 | 18.08% |
| Q2 2012 | 98 ( ) |
$164,409 |  |
437 | |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
See Also
Related News
| Date | Article |
|---|---|
| April 20, 2012 | Statement From Novo Nordisk Regarding the Petition to the FDA By Public Citizen |
| February 18, 2010 | FDA Approved Diabetes Drug Despite Hints at Cancer Risk |
| January 26, 2010 | Victoza Sanctioned for Type 2 Diabetes |
